Table 3.
Exacerbation Management and Outcomes Stratified by Peripheral Eosinophils Less Than or Greater Than 2%
| High Eosinophils ≥2% n = 122 |
Low Eosinophils <2% n = 284 |
P value | |
|---|---|---|---|
| Inpatient Management | |||
| Antibiotics | 84 (68.9) | 234 (82.4) | 0.002 |
| Systemic corticosteroids | 97 (79.5) | 216 (76.1) | 0.448 |
| Oral corticosteroids | 94 (77.0) | 202 (71.1) | 0.218 |
| Intravenous corticosteroids | 21 (17.2) | 65 (22.9) | 0.200 |
| Oxygen | 43 (35.2) | 133 (46.8) | 0.036 |
| ICU | 6 (4.9) | 18 (6.3) | 0.578 |
| Non-invasive ventilation | 5 (4.1) | 14 (4.9) | 0.711 |
| Invasive ventilation | 1 (0.8) | 0 (0.0) | 0.127 |
| Clinical Outcomes | |||
| Length of stay, days | 3.56 (3.05) | 4.40 (4.23) | 0.047 |
| Inpatient mortality | 1 (0.8) | 9 (3.2) | 0.161 |
| 12-month mortality | 5 (4.1) | 21 (7.4) | 0.214 |
Note: Data presented as median (IQR) or number (%) unless otherwise indicated.
Abbreviations: ICU, intensive care unit.